Alterations and hypermethylation of the p14(ARF) gene in gastric cancer

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 654-658

  Iida, Satoru ^a   Akiyama, Yoshimitsu ^a   Nakajima, Tomoko ^a   Ichikawa, Wataru ^a   Nihei, Zenro ^a   Sugihara, Kenichi ^a   Yuasa, Yasuhito ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOME 9P; DNA METHYLATION; EXON; GENE DELETION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STABILITY; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; GENE DELETION; GENE EXPRESSION; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033868629     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<654::AID-IJC6>3.0.CO;2-P     Document Type: Article

References (34)

1. AKIYAMA, Y., YAGI, O.K., ISHIKAWA, T., NAGASAKI, H., SAITOH, K. and YUASA, Y., Genetic alterations are frequent in APC but rare in the TGF-β type II receptor gene in cancer in adenomas of the colon. Cancer Lett., 125, 89-96 (1998).
2. BLIN, N. and STAFFORD, D.W., A general method for isolation of high molecular weight DNA from eukaryotes. Nucl. Acids Res., 3, 2303-2308 (1976).
3. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SKYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. (Genet.). 8, 27-32 (1994).
4. CHOI, S.W., PARK, S.W., LEE, K.Y., KIM, K.M., CHUNG, Y.J. and RHYU, M.G., Fractional allelic loss in gastric carcinoma correlates with growth patterns. Oncogene, 17, 2655-2659 (1998).
5. 7nk40 methylation and p53 mutational status. Cancer Res., 60, 129-133 (2000).
6. ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. Proc. nat. Acad. Sci. (Wash.), 93, 8541-8545 (1996).
7. FUCHS, C.S. and MAYER, R.J., Gastric carcinoma. N. Engl. J. Med., 333, 32-41 (1995).
8. GLEESON, C.M., SLOAN, J.M., MC-GUIGAN, J.A., RITCHIE, A.J., WEBER, J.L. and RUSSELL, S.E.H., Allelotype analysis of adenocarcinoma of the gastric cardia. Brit. J. Cancer, 76, 1455-1465 (1997).
9. GOELZ, S.E., HAMILTON, S.R. and VOGELSTEIN, B., Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem. biophys. Res. Comm., 130, 118-126 (1985).
10. HERMAN, J.G., MERLO, A., MAO, L., LAPIDUS, R.G., ISSA, J.P., DAVIDSON, N.E., SIDRANSKY, D. and BAYLIN, S.B., Inactivation of the CDKN2/p16/ MTS1 gene is frequency associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).
11. HORII, A., NAKATSURU, S., MIYOSHI, Y., ICHII, S., NAGASE, H., KATO, Y., YANAGISAWA, A. and NAKAMURA, Y., The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res., 52, 3231-3233 (1992).
12. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY III, R.S., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
13. 19ARF. Cell. 91, 649-659 (1997).
14. LAURÉN, P., The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 64, 31-49 (1965).
15. INK4b genes in gastric carcinomas. Cancer. 80, 1889-1896 (1997).
16. LIGGETT, W.H., JR., SEWELL, D.A., ROCCO, J., AHRENDT, S.A., KOCH, W. and SIDRANSKY, D., p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro. Cancer Res., 56, 4119-4123 (1996).
17. INKAa transcript. Cancer Res., 55, 2995-2997 (1995).
18. MARKL, I.D.C. and JONKS, P.A., Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res., 58, 5348-5353 (1998).
19. MERLO, A., HERMAN, J.G., MAO, L., LEE, D.J., GABRIELSON, E., BURGER, P.C., BAYLIN, S.B. and SIDRANSKY, D., 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/ CDKN2/MTSI in human cancers. Nature (Med), 1, 686-692 (1995).
20. NANUS, D. M., KELSEN, D. P., MENTLE, I. R., ALTORKI, N. and ALBINO, A. P., Infrequent point mutations of ras oncogenes in gastric cancers. Gastroenterolgy, 98, 955-960 (1990).
21. OTO, M., MIYAKE, S. and YUASA, Y., Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional mmislab gel electrophoresis apparatus. Anal. Biochem., 213, 19-22 (1993).
22. Art, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92, 713-723 (1998).
23. ARF. Proc. nat. Acad. Sci. (Wash.). 94, 669-673 (1997).
24. OUELLE, D.E., ZINDY, F., ASHMUN, R.A. and SHERR, C.J., Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83, 993-1000 (1995).
25. ROBERTSON, K.D. and JONES, P.A., The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. cell. Biol. 18, 6457-6473 (1998).
26. SANCHEZ-CESPEDES, M., REED, A.L., BUTA, M., WU, L., WESTRA, W.H., HERMAN, J.G., YANG., S.C., JEN, J. and SIDRANSKY, D., Inactivation of the 1NK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene, 18, 5843-5849 (1999).
27. SERRANO, M., LEE, H., CHIN, L., CORDON-CARDO, C., BEACH, D. and DKPINHO, R.A., Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85, 27-37 (1996).
28. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
29. STONE, S., JIANG, P., DAYANANTH, P., TAVTIGIAN, S.V., KATCHER, H., PARRY, D., PETERS, G. and KAMB, A., Complex structure and regulation of the p16 (MTSI) locus. Cancer Res., 55, 2988-2994 (1995)
30. TOYOTA, M., AHUJA, N., SUZUKI, H., ITOH, F., OHE-TOYOTA, M., IMAI, K., BAYLIN, S.B. and ISSA, J.P., Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res., 59, 5438-5442(1999).
31. INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene, 17, 2779-2785 (1998).
32. INK4a genes in human esophageal squamous cell carcinoma. Clin. Cancer Res., 5, 2704-2713 (1999).
33. XIONG, Z. and LAIRD, P.W., COBRA: a sensitive and quantitative DNA methylation assay. Nucl. Acids Res., 25, 2532-2534 (1997).
34. ZHANG, Y., XIONG, Y. and YARBROIIGH, W.G., ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92, 725-734 (1998).